Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif

Nature

Volumn 505, Issue 7482, 2014, Pages 229-233

  Guo, Yingying ^a   Dong, Liyong ^a   Qiu, Xiaolin ^a   Wang, Yishu ^a   Zhang, Bailing ^a   Liu, Hongnan ^a   Yu, You ^b   Zang, Yi ^a   Yang, Maojun ^b   Huang, Zhiwei ^a  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR BETA; CULLIN 5; ELONGIN B; ELONGIN C; LIGASE; UNCLASSIFIED DRUG; VIF PROTEIN;

CRYSTAL STRUCTURE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; NEUTRALIZATION; PROTEIN;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CRYSTAL STRUCTURE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; ZINC FINGER MOTIF;

AMINO ACID SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; CRYSTALLOGRAPHY, X-RAY; CULLIN PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84892188402     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12884     Document Type: Article

References (36)

1. Mariani, R. et al. Species-specific exclusion of APOBEC3GfromHIV-1 virions by Vif. Cell 114, 21-31 (2003).
2. Sheehy, A. M., Gaddis, N. C.&Malim, M. H. The antiretroviral enzymeAPOBEC3Gis degraded by the proteasome in response to HIV-1 Vif. Nature Med. 9, 1404-1407 (2003).
3. Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (2003).
4. Stopak, K., de Noronha, C., Yonemoto, W. & Greene, W. C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601 (2003).
5. Marin, M., Rose, K. M., Kozak, S. L. & Kabat, D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nature Med. 9, 1398-1403 (2003).
6. Conticello, S. G., Harris, R. S. & Neuberger, M. S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13, 2009-2013 (2003).
7. Sheehy, A. M.,Gaddis, N. C., Choi, J. D.&Malim, M. H. Isolation of a humangene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650 (2002).
8. Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103 (2003).
9. Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809 (2003).
10. Zhang, H. et al. The cytidinedeaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98 (2003).
11. Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A. J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112 (2003).
12. Stanley, B. J. et al. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J. Virol. 82, 8656-8663 (2008).
13. Luo, K. et al. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc. Natl Acad. Sci. USA 102, 11444-11449 (2005).
14. Zhang, W., Du, J., Evans, S. L., Yu, Y. & Yu, X. F. T-cell differentiation factor CBF-b regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481, 376-379 (2011).
15. Jager, S. et al. Vif hijacks CBF-b to degrade APOBEC3G and promote HIV-1 infection. Nature 481, 371-375 (2011).
16. Kim, Y. K. et al. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes. Acta Crystallogr. D 69, 1587-1597 (2013).
17. Zheng, N. et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703-709 (2002).
18. Stebbins, C. E., Kaelin, W. G. Jr & Pavletich, N. P. Structure of the VHL-ElonginCElonginB complex: implications for VHL tumor suppressor function. Science 284, 455-461 (1999).
19. Bullock, A. N., Debreczeni, J. E., Edwards, A. M., Sundstrom, M. & Knapp, S. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc. Natl Acad. Sci. USA 103, 7637-7642 (2006).
20. Zhou, X., Evans, S. L., Han, X., Liu, Y. & Yu, X. F. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFb and CRL5 E3 ubiquitin ligase components. PLoS ONE 7, e33495 (2012).
21. Taniuchi, I. et al. Differential requirements for Runx proteins inCD4repression and epigenetic silencingduring T lymphocyte development. Cell 111,621-633(2002).
22. Warren, A. J., Bravo, J., Williams, R. L. & Rabbitts, T. H. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFb. EMBO J. 19, 3004-3015 (2000).
23. Kim, D. Y. et al. CBF-b stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol. Cell 49, 632-644 (2013).
24. Hultquist, J. F., McDougle, R. M., Anderson, B. D. & Harris, R. S. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor b on genetically distinct surfaces. AIDS Res. Hum. Retroviruses 28, 1543-1551 (2012).
25. Xiao, Z. et al. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zincbinding domain-stabilized hydrophobic interface in Vif. Virology 349, 290-299 (2006).
26. Zimmerman, E. S., Schulman, B. A. & Zheng, N. Structural assembly of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 20, 714-721 (2010).
27. Chen, G., He, Z.,Wang, T.,Xu, R.&Yu, X. F.A patch of positively chargedamino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J. Virol. 83, 8674-8682 (2009).
28. Russell, R. A.&Pathak, V. K. Identificationof two distincthuman immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J. Virol. 81, 8201-8210 (2007).
29. Zhang, H., Pomerantz, R. J., Dornadula, G. & Sun, Y. Human immunodeficiency virus type 1 Vif protein is an integral component of anmRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol. 74, 8252-8261 (2000).
30. He, Z., Zhang, W., Chen, G., Xu, R.& Yu, X. F. Characterization of conservedmotifs in HIV-1Vif required for APOBEC3G and APOBEC3F interaction. J. Mol. Biol. 381, 1000-1011 (2008).
31. Otwinowski, Z. M. W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
32. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
33. Muniz, J. R. C. et al. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases. J. Mol. Biol. 425, 3166-3177 (2013).
34. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
35. Adams, P. D. et al.PHENIX: buildingnewsoftware for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948-1954 (2002).
36. DeLano, W. L. PyMOL Molecular Viewer (http://www.pymol.org) (2002).